CC BY-NC-ND 4.0 · Journal of Coloproctology 2021; 41(02): 182-187
DOI: 10.1055/s-0041-1726052
Original Article

Polymorphisms of the Vitamin D Receptor Gene in Crohn’s Disease

Polimorfismos do gene do receptor de vitamina D na doença de Crohn
1   School of Medical, Pharmaceutical and Biomedical Sciences, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
,
1   School of Medical, Pharmaceutical and Biomedical Sciences, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
,
2   Faculty of Biomedicine, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil
,
1   School of Medical, Pharmaceutical and Biomedical Sciences, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
,
3   Nursing School, Universidade Federal de Goiás, Goiânia, GO, Brazil
,
1   School of Medical, Pharmaceutical and Biomedical Sciences, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
4   Graduate Program in Environmental Sciences and Health, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
› Author Affiliations

Abstract

Introduction Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory conditions of the gastrointestinal tract. Studies have shown that polymorphisms of the vitamin D receptor (VDR) gene may help elucidate the pathogenesis of CD.

Objectives To analyze the role of VDR gene polymorphisms (ApaI, BsmI, FokI, and TaqI) in the development of CD.

Methods The present study is a systematic review with meta-analysis. a total of 50 articles in English and Portuguese published from 2000 to 2020 were selected from 3 databases. The relationship between CD and the VDR gene was addressed in 16 articles.

Results The TaqI polymorphism was analyzed in 3,689 patients and 4,645 control subjects (odds ratio [OR] = 0.948; 95% confidence interval [95%CI] = 0.851–1.056; p = 0.3467). The ApaI polymorphism was studied in 3,406 patients and 4,415 control subjects (OR = 1,033; 95%CI = 0.854–1.250; p = 0.7356). For FokI polymorphism, there were 2,998 patients and 4,146 control subjects (OR = 0.965; 95%CI = 0.734–1.267; p = 0.7958). Lastly, the BsmI polymorphism was analyzed in 2,981 patients and 4,477 control subjects (OR = 1,272; 95%CI = 0.748–2.161; p = 0.3743).

Conclusion These four VDR gene polymorphisms were not associated with CD. Therefore, further studies with larger samples are required to corroborate or rectify the conclusions from the present meta-analysis.

Resumo

Introdução A doença de Crohn (DC) e a retocolite ulcerativa (RU) são condições inflamatórias crônicas do trato gastrointestinal. Estudos indicam que os polimorfismos do gene do receptor de vitamina D (RVD) são promissores para a patogênese da DC.

Objetivos Avaliar papel dos os polimorfismos do gene do RVD (ApaI, BsmI, FokI e TaqI) no desenvolvimento da DC.

Métodos Trata-se de uma revisão sistemática com metanálise. Foram identificados 50 artigos em inglês e português publicados entre 2000 a 2020 em 3 bases de dados. Destes, foram selecionados 16 artigos que contemplavam a relação entre a DC e o gene do RVD.

Resultados Para o polimorfismo TaqI, a amostra foi composta por 3.689 pacientes e 4.645 controles (razão de probabilidade [RP] = 0,948; intervalo de confiança de 95% [IC95%] = 0,851–1,056; p = 0,3467). Para o polimorfismo ApaI, 3.406 pacientes e 4.415 controles (RP = 1,033; IC95% = 0,854–1,250; p = 0,7356). Para o polimorfismo FokI, 2.998 pacientes e 4.146 controles (RP = 0,965; IC95% = 0,734–1,267; p = 0,7958). E, para o polimorfismo BsmI, 2.981 pacientes e 4.477 controles (RP = 1,272; IC95% = 0,748–2,161; p = 0,3743).

Conclusão Esses quatro polimorfismos do gene do RVD não apresentaram associação com a DC. Logo, sugere-se a realização de mais estudos com amostras maiores a fim de corroborar ou retificar a conclusão desta metanálise.



Publication History

Received: 10 August 2020

Accepted: 07 September 2020

Article published online:
24 May 2021

© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Eloranta JJ, Wenger C, Mwinyi J. et al; Swiss IBD Cohort Study Group. Association of a common vitamin D-binding protein polymorphismwith inflammatory bowel disease. Pharmacogenet Genomics 2011; 21 (09) 559-564
  • 2 Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004; 8 (04) 417-420
  • 3 Gisbert-Ferrándiz L, Salvador P, Ortiz-Masiá D. et al. A single nucleotide polymorphism in the Vitamin D receptor gene is associated with decreased levels of the protein and a penetrating pattern in Crohn’s disease. Inflamm Bowel Dis 2018; 24 (07) 1462-1470
  • 4 Hughes DJ, McManus R, Neary P, O’morain C, O’sullivan M. Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case-control study. Eur J Gastroenterol Hepatol 2011; 23 (09) 807-812
  • 5 Luo YY, Shu XL, Zhao H. et al. Association between vitamin D receptor gene polymorphisms and pediatric Crohn’s disease in China: A study based on gene sequencing. Chin J Contemporary Pediatr 2013; 15 (11) 1006-1008
  • 6 DeSilva P, Ananthakrishnan AN. Vitamin D and IBD: more pieces to the puzzle, still no complete picture. Inflamm Bowel Dis 2012; 18 (07) 1391-1393
  • 7 Xue LN, Xu KQ, Zhang W, Wang Q, Wu J, Wang XY. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: a meta-analysis. Inflamm Bowel Dis 2013; 19 (01) 54-60
  • 8 Chen M, Peyrin-Biroulet L, Xia B, Guéant-Rodriguez RM, Bronowicki JP, Bigard MA, Guéant JL. Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med Genet 2008;9(78)
  • 9 Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66 (02) 121-126
  • 10 Naderi N, Farnood A, Habibi M. et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23 (12) 1816-1822
  • 11 Noble CL, McCullough J HoW. et al. Lowbody mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27 (07) 588-596
  • 12 Szymczak-Tomczak A, Krela-Kaźmierczak I, Kaczmarek-Ryś M. et al. Vitamin Dreceptor (VDR) TaqI polymorphism, vitamin Dand bone mineral density in patients with inflammatory bowel diseases. Adv Clin Exp Med 2019; 28 (07) 955-960
  • 13 Wang L, Wang ZT, Hu JJ, Fan R, Zhou J, Zhong J. Polymorphisms of the vitamin D receptor gene and the risk of inflammatory bowel disease: a meta-analysis. Genet Mol Res 2014; 13 (02) 2598-2610
  • 14 Xia SL, Lin XX, Guo MD. et al. Association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with Crohn’s disease in Chinese patients. J Gastroenterol Hepatol 2016; 31 (04) 795-801
  • 15 Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn’s disease susceptibility. Gut 2000; 47 (02) 211-214
  • 16 Cho YA, Lee J, Oh JH. et al. Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma. Sci Rep 2018; 8 (01) 12899
  • 17 Bentley RW, Keown D, Merriman TR. et al. Vitamin D receptor gene polymorphismassociated with inflammatory bowel disease in New Zealand males. Aliment Pharmacol Ther 2011; 33 (07) 855-856
  • 18 Limketkai BN, Singla MB, Rodriguez B. et al. Levels of Vitamin D Are Low After Crohn’s Disease Is Established But Not Before. Clin Gastroenterol Hepatol 2020; 18 (08) 1769-1776.e1